Activity Provided By:

Penn State College of Medicine

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

Overview / Abstract:	This recording from a series of expert-led small group meet-ups will increase your knowledge of RET inhibitors, help you gain confidence in utilizing biomarkers to inform treatment decisions, and improve collaboration between oncologists and pathologists to optimize precision medicine for RET-positive metastatic NSCLC and advanced thyroid cancer.
Expiration	Jan 28, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Webinar / Webcast / Video
Credits / Hours	AMA PRA Category 1 Credit™ and ABPath Continuing Certification
Accreditation	ACCME and American Board of Pathology
Presenters / Authors / Faculty	Marcia Brose, MD, PhD, FASCO Director, Cancer Services Vice Chair, Hematology and Medical Oncology Co-Director Community Based Clinical Trials Sidney Kimmel Cancer Center - Jefferson Health Philadelphia, PA Justin Gainor, MD Associate Professor of Medicine at Harvard Medical School Director, Center for Thoracic Cancers Director of Targeted Immunotherapy Massachusetts General Hospital Boston, MA
Activity Specialities / Related Topics	Oncology / Cancer / Radiation Therapy, Pathology
Sponsors / Supporters / Grant Providers	Sponsored by the Academy for Continued Healthcare Learning (ACHL) and Penn State College of Medicine. This activity is supported by an educational grant from Lilly and Genentech, Inc.
Keywords / Search Terms	ACHL CME/CE, CME, CE, Penn State University College of Medicine, RET+, NSCLC, Thyroid Cancer, Cancer, oncologists, pathologists, oncology, pathology, RET inhibition, tumor, non–small cell lung cancer, RET testing, solid tumor, biomarker testing Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map